Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Feb 18, 2026
Sale
Shares
1,276
Price
$79.97
Total Value
$102.04K
Shares Held After
0
% of Holdings
100.0%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Feb 18, 2026
Sale
Shares
3,026
Price
$79.16
Total Value
$239.53K
Shares Held After
1,276
% of Holdings
70.3%

Voyager Therapeutics, Inc. (VYGR)

Carter Todd Alfred — Chief Scientific Officer
Feb 18, 2026
Sale
Shares
3,301
Price
$3.44
Total Value
$11.36K
Shares Held After
149,892
% of Holdings
2.2%

Keros Therapeutics, Inc. (KROS)

Cho Esther — SVP, General Counsel
Feb 18, 2026
Sale
Shares
4,745
Price
$16.35
Total Value
$77.58K
Shares Held After
39,755
% of Holdings
10.7%
Feb 18, 2026
Sale
Shares
11,732
Price
$3.41
Total Value
$40.01K
Shares Held After
498,257
% of Holdings
2.3%

RECURSION PHARMACEUTICALS, INC. (RXRX)

Taylor Ben R — Chief Financial Officer
Feb 18, 2026
Sale
Shares
13,426
Price
$3.08
Total Value
$41.35K
Shares Held After
1,195,349
% of Holdings
1.1%

KalVista Pharmaceuticals, Inc. (KALV)

Yea Christopher — CHIEF DEVELOPMENT OFFICER
Feb 18, 2026
Sale
Shares
1,109
Price
$15.00
Total Value
$16.64K
Shares Held After
224,173
% of Holdings
0.5%

KalVista Pharmaceuticals, Inc. (KALV)

Audhya Paul K. — CHIEF MEDICAL OFFICER
Feb 18, 2026
Sale
Shares
1,163
Price
$15.00
Total Value
$17.45K
Shares Held After
133,087
% of Holdings
0.9%
Feb 18, 2026
Sale
Shares
1,038
Price
$15.00
Total Value
$15.57K
Shares Held After
429,667
% of Holdings
0.2%
Feb 18, 2026
Sale
Shares
2,100
Price
$29.80
Total Value
$62.57K
Shares Held After
20,729
% of Holdings
9.2%
Feb 18, 2026
Sale
Shares
2,983
Price
$29.04
Total Value
$86.64K
Shares Held After
22,829
% of Holdings
11.6%
Feb 18, 2026
Sale
Shares
2,281
Price
$29.80
Total Value
$67.97K
Shares Held After
556,247
% of Holdings
0.4%
Feb 18, 2026
Sale
Shares
3,552
Price
$29.05
Total Value
$103.19K
Shares Held After
558,528
% of Holdings
0.6%

EXELIXIS, INC. (EXEL)

Smith Julie — Director
Feb 18, 2026
Sale
Shares
20,030
Price
$44.30
Total Value
$887.33K
Shares Held After
20,590
% of Holdings
49.3%

EXELIXIS, INC. (EXEL)

Smith Julie — Director
Feb 18, 2026
Sale
Shares
44,087
Price
$44.50
Total Value
$1.96M
Shares Held After
20,590
% of Holdings
68.2%

GERON CORP (GERN)

ROBERTSON MICHELLE — EVP, CHIEF FINANCIAL OFFICER
Feb 18, 2026
Sale
Shares
9,855
Price
$1.94
Total Value
$19.12K
Shares Held After
17,645
% of Holdings
35.8%
Feb 18, 2026
Sale
Shares
3,081
Price
$69.36
Total Value
$213.70K
Shares Held After
108,231
% of Holdings
2.8%

Gemini Therapeutics, Inc. (GMTX)

Franchi Jean M. — Chief Financial Officer
Feb 18, 2026
Sale
Shares
3,684
Price
$65.89
Total Value
$242.73K
Shares Held After
71,343
% of Holdings
4.9%

Gemini Therapeutics, Inc. (GMTX)

Franchi Jean M. — Chief Financial Officer
Feb 18, 2026
Sale
Shares
3,397
Price
$65.01
Total Value
$220.84K
Shares Held After
75,027
% of Holdings
4.3%
Feb 18, 2026
Sale
Shares
5,965
Price
$32.35
Total Value
$192.97K
Shares Held After
5,859
% of Holdings
50.4%

Immunocore Holdings plc (IMCR)

St Leger Tina Amber — CHIEF HR OFFICER
Feb 18, 2026
Sale
Shares
1,000
Price
$32.35
Total Value
$32.35K
Shares Held After
1,119
% of Holdings
47.2%

Immunocore Holdings plc (IMCR)

GOLL JOHN — SVP, FINANCE & CAO
Feb 18, 2026
Sale
Shares
698
Price
$32.35
Total Value
$22.58K
Shares Held After
653
% of Holdings
51.7%
Feb 18, 2026
Sale
Shares
11,474
Price
$32.35
Total Value
$371.18K
Shares Held After
12,343
% of Holdings
48.2%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Feb 18, 2026
Sale
Shares
368
Price
$473.68
Total Value
$174.31K
Shares Held After
48,650
% of Holdings
0.8%

Precision BioSciences, Inc. (DTIL)

SMITH J. JEFFERSON — Chief Research Officer
Feb 18, 2026
Sale
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
121,926
% of Holdings
3.9%
Feb 18, 2026
Sale
Shares
20,559
Price
$3.84
Total Value
$78.95K
Shares Held After
243,392
% of Holdings
7.8%

Precision BioSciences, Inc. (DTIL)

Scimeca Dario — General Counsel and Secretary
Feb 18, 2026
Sale
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
56,457
% of Holdings
8.0%

Precision BioSciences, Inc. (DTIL)

Kelly John Alexander — Chief Financial Officer
Feb 18, 2026
Sale
Shares
8,149
Price
$3.84
Total Value
$31.29K
Shares Held After
125,883
% of Holdings
6.1%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Ambrose Kristen — SVP & Chief Accounting Officer
Feb 18, 2026
Sale
Shares
638
Price
$473.68
Total Value
$302.21K
Shares Held After
7,750
% of Holdings
7.6%

Seer, Inc. (SEER)

Farokhzad Omid — Director
Feb 18, 2026
Sale
Shares
24,385
Price
$1.99
Total Value
$48.65K
Shares Held After
3,349,064
% of Holdings
0.7%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Feb 18, 2026
Sale
Shares
817
Price
$473.68
Total Value
$387.00K
Shares Held After
20,727
% of Holdings
3.8%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Biller Jonathan — EVP and Chief Legal Officer
Feb 18, 2026
Sale
Shares
1,244
Price
$473.68
Total Value
$589.26K
Shares Held After
15,748
% of Holdings
7.3%

Seer, Inc. (SEER)

Horn David R. — PRESIDENT & CFO
Feb 18, 2026
Sale
Shares
7,743
Price
$1.99
Total Value
$15.45K
Shares Held After
501,262
% of Holdings
1.5%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Bunnage Mark E. — EVP, Chief Scientific Officer
Feb 18, 2026
Sale
Shares
1,182
Price
$473.68
Total Value
$559.89K
Shares Held After
8,486
% of Holdings
12.2%
Feb 18, 2026
Sale
Shares
16,644
Price
$5.82
Total Value
$96.92K
Shares Held After
235,405
% of Holdings
6.6%

Solid Biosciences Inc. (SLDB)

Brooks Gabriel — Chief Medical Officer
Feb 18, 2026
Sale
Shares
0
Price
$5.82
Total Value
$0.00
Shares Held After
89,466
% of Holdings
0.0%

Solid Biosciences Inc. (SLDB)

Tan Kevin — CFO & Treasurer
Feb 18, 2026
Sale
Shares
5,404
Price
$5.82
Total Value
$31.47K
Shares Held After
99,422
% of Holdings
5.2%

Solid Biosciences Inc. (SLDB)

Howton David T — Chief Operating Officer
Feb 18, 2026
Sale
Shares
7,469
Price
$5.82
Total Value
$43.49K
Shares Held After
105,077
% of Holdings
6.6%
Feb 18, 2026
Sale
Shares
2,658
Price
$5.82
Total Value
$15.48K
Shares Held After
27,474
% of Holdings
8.8%

Solid Biosciences Inc. (SLDB)

Herzich Paul — Chief Technology Officer
Feb 18, 2026
Sale
Shares
3,616
Price
$5.82
Total Value
$21.06K
Shares Held After
72,638
% of Holdings
4.7%

Solid Biosciences Inc. (SLDB)

Hanrahan Jessie — Chief Regulatory Officer
Feb 18, 2026
Sale
Shares
4,134
Price
$5.82
Total Value
$24.07K
Shares Held After
74,318
% of Holdings
5.3%

Adagio Therapeutics, Inc. (ADGI)

Andersen Jill — Chief Legal Officer, Secretary
Feb 18, 2026
Sale
Shares
34,939
Price
$1.58
Total Value
$55.13K
Shares Held After
181,736
% of Holdings
16.1%

Adagio Therapeutics, Inc. (ADGI)

Lee Timothy Edward — Chief Commercial Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
117,717
% of Holdings
15.1%

EXELIXIS, INC. (EXEL)

Hefti Brenda — SVP and General Counsel
Feb 18, 2026
Sale
Shares
18,669
Price
$44.01
Total Value
$821.62K
Shares Held After
96,512
% of Holdings
16.2%

Adagio Therapeutics, Inc. (ADGI)

Duke William E. — Chief Financial Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%

Adagio Therapeutics, Inc. (ADGI)

Green Julie — Chief Human Resources Officer
Feb 18, 2026
Sale
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%

Adagio Therapeutics, Inc. (ADGI)

Allen Robert D. III — Chief Scientific Officer
Feb 18, 2026
Sale
Shares
19,392
Price
$1.58
Total Value
$30.60K
Shares Held After
114,487
% of Holdings
14.5%
Feb 18, 2026
Sale
Shares
9,673
Price
$1.71
Total Value
$16.54K
Shares Held After
392,700
% of Holdings
2.4%
Feb 18, 2026
Sale
Shares
30,843
Price
$1.71
Total Value
$52.74K
Shares Held After
4,403,277
% of Holdings
0.7%

Avista Public Acquisition Corp. II (AHPA)

GUSTAFSON KURT A — Executive VP, Finance and CFO
Feb 18, 2026
Sale
Shares
9,301
Price
$1.71
Total Value
$15.90K
Shares Held After
268,851
% of Holdings
3.3%
Version: v26.3.33